All In Biotech

Drug Trial Radar · NCT04739059

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema

Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

171

Actual

Start

Mar 29, 2021

Primary completion

Nov 21, 2025

Study completion Nov 21, 2025

Sponsor

Lead sponsor
CSL BehringIndustry
Sponsor type
Industry
First posted
Feb 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as garadacimab) when administered subcutaneously (SC)

Conditions

  • Hereditary Angioedema

Interventions

  • CSL312Biological

    Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAE)Time frame: Approximately up to 54 months
  2. Percentage of Participants With TEAETime frame: Approximately up to 54 months
  3. Number of TEAETime frame: Approximately up to 54 months
  4. TEAE Rates Per InjectionTime frame: Approximately up to 54 months
  5. TEAE Rates Per Participant YearTime frame: Approximately up to 54 months

Locations

44 sites in 14 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama

    Birmingham, Alabama

  • Research Solutions of Arizona

    Litchfield Park, Arizona

  • Medical Research of Arizona

    Scottsdale, Arizona

  • Little Rock Allergy & Asthma Clinic

    Little Rock, Arkansas

  • Donald S. Levy M.D.

    Orange, California

  • Raffi Tachdjian MD, Inc.

    Santa Monica, California

  • Allergy & Asthma Clinical Research

    Walnut Creek, California

  • Institute for Asthma and Allergy PC

    Chevy Chase, Maryland

  • Bernstein Clinical Research Center, LLC

    Cincinnati, Ohio

  • PennState Health Milton S. Hershey Medical Center

    Hershey, Pennsylvania

  • AARA Research Center

    Dallas, Texas

  • Campbelltown Hospital / Western Sydney University

    Campbelltown, New South Wales, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Fiona Stanley Hospital, Department of Clinical Immunology

    Murdoch, Western Australia, Australia

  • University of Alberta - Research Transition Facility

    Edmonton, Alberta, Canada

  • McMaster University

    Hamilton, Ontario, Canada

  • Ottawa Allergy Research Corp

    Ottawa, Ontario, Canada

  • Gordon Sussman Clinical Research

    Toronto, Ontario, Canada

  • Montreal Clinical Research Institute

    Montreal, Quebec, Canada

  • University hospital St. Anna Ustav klinicke imunologie a alergologie, Fakultní nemocnice u sv. Anny v Brně

    Brno, Czechia

  • University Hospital Motol

    Prague, Czechia

  • Charité - Universitätsmedizin Berlin

    Berlin, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt, Germany

  • Johannes Gutenberg-Universität KöR, Hautklinik und Poliklinik der Universitätsmedizin, Clinical Research Center

    Mainz, Germany

  • HZRM Haemophilie Zentrum Rhein Main GmbH

    Mörfelden-Walldorf, Germany

  • The University of Hong Kong, Queen Mary Hospital

    Hong Kong, Hong Kong

  • Semmelweis Egyetem Altalanos Orvostudományi Kar Belgyógyászati és Hematológiai Klinika

    Budapest, Hungary

  • Barzilai University Medical Center

    Ashkelon, Israel

  • Koga Community Hospital

    Shizuoka, Daikakuji Yaizu-shi, Japan

  • Mie University Hospital

    Mie, Edobashi, Tsu-shi, Japan

  • Juntendo University Hospital

    Tokyo, Hongo Bunkyo-ku, Japan

  • Saitama Medical Center

    Saitama, Kamoda Kawagoe-shi, Japan

  • St. Marianna University School of Medicine Hospital

    Kanagawa, Kawasaki-shi, Japan

  • Clover Hospital

    Kanagawa, Kugenumaishigami, Fujisawa-shi, Japan

  • Saiyu Soka Hospital

    Saitama, Matsubara Soka-shi, Japan

  • National Hospital Organization Disaster Medical Center

    Tokyo, Midoricho, Tachikawa-shi, Japan

  • Saga University Hospital

    Saga, Nebeshima, Saga-shi, Japan

  • Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital

    Miyakojima-ku, Osaka-shi, Japan

  • Amsterdam UMC, location AMC

    Amsterdam, Netherlands

  • Auckland City Hospital

    Grafton, Auckland, New Zealand

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.